BTCT vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

BTCT

43.9
AI Score
VS
NIVF Wins

NIVF

45.4
AI Score

Investment Advisor Scores

BTCT

44score
Recommendation
HOLD

NIVF

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BTCT NIVF Winner
Revenue 14.04M 4.73M BTCT
Net Income -9.06M 9.88M NIVF
Gross Margin -22.5% 20.2% NIVF
Net Margin -64.5% 209.0% NIVF
Operating Income -8.81M -10.73M BTCT
ROE -24.4% 37.1% NIVF
ROA -22.7% 30.2% NIVF
Total Assets 39.92M 32.72M BTCT
Cash 350,000 758,621 NIVF
Current Ratio 7.79 3.12 BTCT
Free Cash Flow -13.78M -11.06M NIVF

Relative Price Performance (Last 90 Days)

BTCT 1M: -50.9% · 3M: -57.7% NIVF 1M: +41.7% · 3M: -61.8%

Current Technical Phase

BTCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.9%), weak momentum, RSI 26

RSI (14): 25.7 · Price: $0.52

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 31

RSI (14): 31.3 · Price: $0.65

Fundamentals Snapshot

Metric BTCT NIVF
Market Cap
Forward P/E -0.1 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin -0.2% 0.2%
Operating Margin -0.5% -3.5%
EPS -1.10 109.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.